PhaseBio Pharmaceuticals, Inc. (PHAS) News PHAS Home News Ratings Charts PhaseBio Pharmaceuticals, Inc. (PHAS): $0.07 0.02 (-26.21%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum D Stability D Sentiment Get Rating Quality D Add PHAS to Watchlist Sign Up Industry: Medical - Pharmaceuticals Industry NR Ranked #119 of 164 in industry See All 'A' Rated Buy Stocks Filter PHAS News Items All News Types Featured Stories Commentary Search PHAS News Results Date Symbol Company Title Start End Change POWR Rating Loading, please wait... Load More News Items Most Popular Stories View All • Stock Investors: Are You “Fed Up”? • 3 Streaming Giants Ending the Year on a High Note • 3 Gold Miners Glittering with High Upsides • 3 Digital Entertainment Companies Capitalizing on Streaming Growth • Is the Stock Market in a Rolling Correction? View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe
